Education: Intermediate (MPC / Bi.PC), ITI, Diploma, or B.Sc in Chemistry.
Age Limit: 18 to 21 years.
Graduation Year: 2023 or 2024.
Academic Performance: Minimum 50% aggregate in all academics.
Gender: Male and Female candidates are eligible.
Alert: Genuine jobs never ask for money. Don’t pay anyone! Stay safe!
Special Training Program:
Shortlisted Intermediate candidates will undergo a 60-day Skill Development Training at Swarna Bharat Trust. During this period, participants will receive free accommodation, food, books, and shoes, along with a stipend of ₹5,000 per month.
Upon successful completion of the training, candidates will be considered for employment at Granules India Ltd, subject to a pre-interview.
Documents to Bring:
- All Educational Certificates.
- Aadhar and PAN Cards.
- Two Passport Size Photographs.
Date: February 28, 2025 (Friday).
Time: 10:00 AM to 12:00 PM.
Venue: Granules India Ltd, Gagillapur Unit, Dundigal, Hyderabad, Telangana - 500043.
Contact: 08418-696400.
This walk-in drive is a significant opportunity for freshers aiming to build a career in the pharmaceutical sector. Granules India is known for its commitment to quality and innovation, making it a desirable workplace for aspiring professionals.
Note: Candidates should be prepared for shift operations and are advised to arrive at the venue on time with all necessary documents.
Introduction to Granules India Limited:
The pharmaceutical company Granules India Limited which has operations at its headquarters in Hyderabad operates as a prominent Indian institution that has existed during four decades. The company launched in 1984 as Triton Laboratories decided to produce Paracetamol API at its Bonthapally facility.
Through its long evolution the company transformed from Triton Laboratories into Granules India which now operates as a vertical pharmaceutical leader serving worldwide clients with various products and services.
Vertically Integrated Operations:
Granules India operates a vertical integration scheme which leads pharmaceutical businesses through Active Pharmaceutical Ingredients (APIs) to Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs).
Through their complete approach to operations this company guarantees robust quality management together with efficient operational costs and rapid product market availability.
The firm operates modern manufacturing centers that manufacture at exceptional scales through their industry-leading batch production processing capacity of 24,640 TPA for PFIs to serve international customers.
Commitment to Research and Development:
Innovation serves as the fundamental principle that drives the operations of Granules India. The company operates completely focused research and development centers at Pune and Hyderabad to deliver economical manufacturing approaches together with varied product systems.
The R&D division of Granules India works on developing premium quality APIs PFIs and FDs according to the modern requirements of the pharmaceutical market.
Due to its innovative approach Granules India has earned a position as a trusted business partner for pharmaceutical market leaders throughout the world.
Global Presence and Partnerships:
The core business model of Granules India includes worldwide market penetration for regulated and developing market clients. The pharmaceutical organization has developed successful partnerships that have built its international market presence.
The subsidiary Granules USA established by Granules India allows the company to supply high-quality pharmaceutical products across the United States thus broadening its client base.
Milestones and Achievements:
The enterprise Granules India reached important business goals during its operational timeline. The company established itself as an industry leader by developing bulk granulated Paracetamol in the early 1990s while opening advanced manufacturing units for Oncology and High Potent APIs in Visakhapatnam during 2016.
The company demonstrates continuous dedication to offer affordable safe and effective pharmaceutical solutions worldwide through these achievements.
Core Values and Vision:
Granules India follows three core principles to direct their operations towards putting customers first while achieving innovation and operational milestones.
Granules India aims to improve worldwide healthcare quality through accessible and affordable pharmaceutical offerings of high excellence. The organization applies this mission to every part of its business which includes research development along with manufacturing and distribution operations.
The pharmaceutical sector commemorates Granules India Limited as an organization which demonstrates consistent progress through innovative solutions alongside a deep dedication.
Through its vertically integrated business model and robust research and development efforts and worldwide collaborations the company advances the delivery of healthcare solutions of high quality to the world's people.